Artículos de revistas
Thymidylate Synthase Gene (tyms) Polymorphisms In Sporadic And Hereditary Breast Cancer
Registro en:
Bmc Research Notes. , v. 5, n. , p. - , 2012.
17560500
10.1186/1756-0500-5-676
2-s2.0-84872377152
Autor
Da Silva Nogueira Junior J.
De Lima Marson F.A.
Bertuzzo C.S.
Institución
Resumen
Background: Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of breast cells in a disorderly. In Brazil, there are approximately 49.240 new cases of BC, every year. The BC etiology is still poorly understood. The BC can be sporadic (SBC) or hereditary (HBC). Recent studies have correlated gene polymorphisms with the BC, such as alterations in thymidylate synthase gene (TYMS), which are used to improve diagnosis and prevention of the disease. Polymorphisms in the TYMS gene 5'-UTR region, usually present reps double (2R) and/or triple (3R). Studies have shown that homozygous 3R/3R is overexpressed compared with 2R/2R genotype, and these polymorphic variations may contribute to individual susceptibility to the development of BC. In this context, the objective of this study was to evaluate the frequency of the TYMS 2R and 3R polymorphisms, comparing genotypic and allelic distribution with SBC and HBC patients. Methods. In this study we included a total of 204 subjects, 70 with BC (33 with SBC, and 37 with HBC) and 134 healthy subjects (controls). The Polymerase Chain Reaction was the method used. Results: Results demonstrated a high frequency of the 3R allele at BC, SBC, and HBC groups. The frequency of genotype 2R/3R was significantly higher in BC group. This work showed association between the 2R/3R variants (OR = 4.14, CI95% = 1.77-9.71) in the development of SBC, and 2R/2R (OR = 0.233, CI95% = 1.63-7.65) and 2R/3R (OR = 3.53, CI95% = 0.06-0.81) for developing HBC. To BC, there was association with the genotype 2R/3R (OR: 3.79, CI95% = 2.03-7.08). Conclusion: Our results show relation to the development of BC in association with the analyzed polymorphisms. © 2012 Junior et al.; licensee BioMed Central Ltd. 5
(2011) Cancer, , http://www.who.int/cancer/en/, World Health Organization WHO [Acess: 2011 Jul. 27] Zou, Y.F., Wang, F., Feng, X.L., The association between two polymorphisms in the TYMS gene and breast cancer risk: Appraisal of a recent meta-analysis (2011) Breast Cancer Res Treat, 128 (1), pp. 289-290. , 10.1007/s10549-011-1390-9 21327463 Henríquez-Hernández, L.A., Murias-Rosales, A., Hernández González, A., Cabrera De León, A., Díaz-Chico, B.N., Mori De Santiago, M., Fernández Pérez, L., Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study (2009) Oncol Rep, 22 (6), pp. 1425-1433. , 19885596 Van Der Groep, P., Bouter, A., Van Der Zanden, R., Siccama, I., Menko, F.H., Gille, J.J.P., Van Kalken, C., Van Diest, P.J., Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data (2006) Journal of Clinical Pathology, 59 (6), pp. 611-617. , DOI 10.1136/jcp.2005.032151 Van Diest, P.J., No consent should be needed for using leftover body material for scientific purposes (2002) BMJ, 325, pp. 648-651. , 10.1136/bmj.325.7365.648 12269316 Kenemans, P., Verstraeten, R.A., Verheijen, R.H.M., Oncogenic pathways in hereditary and sporadic breast cancer (2004) Maturitas, 49 (1), pp. 34-43. , DOI 10.1016/j.maturitas.2004.06.005, PII S0378512204002075 Latimer, J.J., Johnson, J.M., Kelly, C.M., Miles, T.D., Beaudry-Rodgers, K.A., Lalanne, N.A., Vogel, V.G., Grant, S.G., Nucleotide excision repair deficiency is intrinsic in sporadic stage i breast cancer (2010) PNAS, 107 (50), pp. 21725-21730. , 10.1073/pnas.0914772107 21118987 Henríquez-Hernández, L.A., Pérez, L.F., González, A.H., León, A.C., Díaz-Chico, B.N., Rosales, A.M., TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy (2010) Cancer Epidemiol, 34, pp. 490-493. , 10.1016/j.canep.2010.03.004 20371218 Jakobsen, A., Nielsen, N.J., Gyldenkerne, N., Lindeberg, J., Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity (2005) J Clin Oncol, 23, pp. 1365-1369. , 10.1200/JCO.2005.06.219 15735113 Lecomte, T., Ferraz, J.-M., Zinzindohoue, F., Loriot, M.-A., Tregouet, D.-A., Landi, B., Berger, A., Laurent-Puig, P., Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy (2004) Clinical Cancer Research, 10 (17), pp. 5880-5888. , DOI 10.1158/1078-0432.CCR-04-0169 Wang, J., Wang, B., Bi, J., Di, J., The association between two polymorphisms in the TYMS gene and breast cancer risk: A meta-analysis (2011) Breast Cancer Res Treat, 128, pp. 203-209. , 10.1007/s10549-010-1314-0 21188629 Zhai, X., Gao, J., Hu, Z., Tang, J., Qin, J., Wang, S., Wang, X., Shen, H., Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: A case-control analysis (2006) BMC Cancer, 6, p. 138. , DOI 10.1186/1471-2407-6-138 Feng, I.J., Radivoyevitch, T., SNP-SNP interactions between dNTP supply enzymes and mismatch DNA repair in breast cancer (2009) Proc Ohio Collab Conf Bioinform, 15, pp. 123-128 Calascibetta, A., Contino, F., Feo, S., Gulotta, G., Cajozzo, M., Antona, A., Sanguedolce, G., Sanguedolce, R., Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-fluorouracil drug response (2009) J of Nucleic Acids, 2010, pp. 1-4 Fariña-Sarasqueta, A., Gosens, M., Moerland, E., Lijnschoten, I.V., Lemmens, V., Slooter, G.D., Rutten, H.J.T., Van Den Brule, A.J.C., TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients (2010) Anal Cell Pathol/Cell Oncol, 33, pp. 1-11 Bonadia, L.C., (2004) Estudo de Associação Entre Polimorfismos em Genes Que Codificam Enzimas Participantes Do Metabolismo Do Folato e A Formação de Embriões Com Aberrações Cromossômicas, , Campinas: Dissertação [Mestrado em Ciências Médicas]. Departamento de Genética Médica, Universidade Estadual de Campinas (2011) SPSS 17.0 for Windows (Computer Program). Statistical Package for Social Science (SPSS). Release Version 17.0.1. Chicago (IL): SPSS. Incorporation, , http://www.spss.com Barrett, J.C., Fry, B., Maller, J., Daly, M.J., Haploview: Analysis and visualization of LD and haplotype maps (2005) Bioinformatics, 21 (2), pp. 263-265. , DOI 10.1093/bioinformatics/bth457 Dunning, A.M., Healey, C.S., Pharoah, P.D.P., Teare, M.D., Ponder, B.A.J., Easton, D.F., A systematic review of genetic polymorphisms and breast cancer risk (1999) Cancer Epidemiology Biomarkers and Prevention, 8 (10), pp. 843-854 Kawakita, D., Matsuo, K., Sato, F., Oze, I., Hosono, S., Ito, H., Watanabe, M., Tanaka, H., Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma (2012) Ann Oncol, 23 (1), pp. 186-192. , 10.1093/annonc/mdr057 21460376 Ghosh, S., Winter, J.M., Patel, K., Kern, S.E., Reexamining a proposal thymidylate synthase 5'-untranslated region as a regulator of translation efficiency (2011) Cancer Biol Ther, 12 (8), pp. 750-755. , 10.4161/cbt.12.8.16867 21811101 Brown, K.S., Kluijtmans, L.A.J., Young, I.S., McNulty, H., Mitchell, L.E., Yarnell, J.W.G., Woodside, J.V., Whitehead, A.S., The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects (2004) Human Genetics, 114 (2), pp. 182-185. , DOI 10.1007/s00439-003-1039-9 Düzgün, N., Duman, T., Morris, Y., Tutkak, H., Köse, K., Ertuǧrul, E., Aydintuǧ, O.T., Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease (2008) Clin Rheumatol, 27, pp. 1221-1225. , 10.1007/s10067-008-0889-x 18458991 Uchida, K., Hayashi, K., Kawakami, K., Schneider, S., Yochim, J.M., Kuramochi, H., Takasaki, K., Danenberg, P.V., Loss of Heterozygosity at the Thymidylate Synthase (TS) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for A 28-bp Polymorphism in the TS Gene (2004) Clinical Cancer Research, 10 (2), pp. 433-439. , DOI 10.1158/1078-0432.CCR-0200-03 Brody, J.R., Hucl, T., Gallmeier, E., Winter, J.M., Kern, S.E., Murphy, K.M., Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: A model for patient classification to aid fluoropyrimidine therapy (2006) Cancer Research, 66 (19), pp. 9369-9373. , DOI 10.1158/0008-5472.CAN-06-2165 Hur, H., Kang, J., Kim, N.K., Min, B.S., Lee, K.Y., Shin, S.J., Keum, K.C., Lee, M.Y., Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer (2011) J Radiat Oncol Biol Phys, 81 (3), pp. 669-676. , 10.1016/j.ijrobp.2010.06.049 Tan, B.R., Thomas, F., Myerson, R.J., Zehnbauer, B., Trinkaus, K., Malyapa, R.S., Mutch, M.G., McLeod, H.L., Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma (2011) J Clin Oncol, 45, pp. 1-10 Tanaka, F., Wada, H., Fukui, Y., Fukushima, M., Thymidylate synthase (TS) gene expression in primary lung cancer patients: A large-scale study in Japanese population (2011) Ann Oncol, 22 (8), pp. 1791-1797. , 10.1093/annonc/mdq730 21321092 Weekes, C.D., Nallapareddy, S., Rudek, M.A., Norris-Kirby, A., Laheru, D., Jimeno, A., Donehower, R.C., Messersmith, W.A., Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer (2011) Invest New Drugs, 29, pp. 1057-1065. , 10.1007/s10637-010-9413-7 20306339 Wynes, M.W., Dziadziuszko, R., Singh, S., Ranger-Moore, J., Szostakiewicz, B., Dziadziuszko, K., Jassem, J., Hirsch, F.R., Thymidylate synthase (TS) gene copy number in NSCLC (2010) J Clin Oncol, 28 (15), pp. 21063-21067 Skibola, C.F., Forrest, M.S., Coppedé, F., Agana, L., Hubbard, A., Smith, M.T., Bracci, P.M., Holly, E.A., Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma (2004) Blood, 104 (7), pp. 2055-2062 Liersch, T., Langer, C., Ghadimi, B.M., Kulle, B., Aust, D.E., Baretton, G.B., Schwabe, W., Jakob, C., Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy (2006) Journal of Clinical Oncology, 24 (25), pp. 4062-4068. , DOI 10.1200/JCO.2005.04.2739 Kawakami, K., Omura, K., Kanehira, E., Watanabe, Y., Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers (1999) Anticancer Research, 19 (4 B), pp. 3249-3252 Trinh, B.N., Ong, C.-N., Coetzee, G.A., Yu, M.C., Laird, P.W., Thymidylate synthase: A novel genetic determinant of plasma homocysteine and folate levels (2002) Human Genetics, 111 (3), pp. 299-302. , DOI 10.1007/s00439-002-0779-2 Xi, Y., Nakajima, G., Schmitz, J.C., Chu, E., Ju, J., Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer (2006) BMC Genom, 7, pp. 68-83. , 10.1186/1471-2164-7-68 Calascibetta, A., Contino, F., Feo, S., Gulotta, G., Cajozzo, M., Antona, A., Sanguedolce, G., Sanguedolce, R., Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-fluorouracil drug response (2010) J of Nucl Acids, 2010, pp. 1-4 Mauritz, R., Giovannetti, E., Beumer, I.J., Smid, K., Van Groeningen, C.J., Pinedo, H.M., Peters, G.J., Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer (2009) Clin Colorectal Cancer, 8 (3), pp. 146-154. , 10.3816/CCC.2009.n.024 19632929 Gusella, M., Padrini, R., G>C SNP of thymidylate synthase with respect to colorectal cancer (2007) Pharmacogenomics, 8 (8), pp. 985-996. , http://www.futuremedicine.com/doi/pdf/10.2217/14622416.8.8.985, DOI 10.2217/14622416.8.8.985 Martinez-Balibrea, E., Abad, A., Martínez-Cardús, A., Ginés, A., Valladares, M., Navarro, M., Aranda, E., Moreno, V., UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy (2010) BJ of Cancer, 103, pp. 581-589. , 10.1038/sj.bjc.6605776 (2006) Parâmetros Técnicos Para Programação de Ações de Detecção Precoce Do Câncer de Mama. Recomendações Para Gestores Estaduais e Municipais, , http://www.inca.gov.br/inca/Arquivos/publicacoes/Parametrostexto.pdf, Ministério da Saúde. Instituto Nacional de Câncer Ministério da Saúde RJ Rio de Janeiro [Acess: 2011 dez. 13]